EP3529262
Aðferðir til að örva T-eitilfrumuviðbrögð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.10.2017EP published:
21.7.2021EP application number:
17797066.2
EP translation filed:
2.9.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
19.10.2037Expiry date:
19.10.2026Next due date:
31.10.2026
Title:
METHODS FOR PROMOTING T CELLS RESPONSE
Timeline
Today
20.10.2017EP application
21.7.2021EP Publication
2.9.2021Translation submitted
15.9.2021Registration published
19.10.2026Expires
Owner
Name:
INSERM - Institut National de la Santé et de la Recherche MédicaleAddress:
101, rue de Tolbiac, 75013 Paris, FR
Name:
OSE ImmunotherapeuticsAddress:
22 Boulevard Benoni Goullin, 44200 Nantes, FR
Name:
NANTES UNIVERSITEAddress:
1 QUAI DE TOURVILLE, BP 13522, 44035 NANTES CEDEX 1, FR
Inventor
Name:
CHIFFOLEAU, EliseAddress:
44093 Nantes - Cedex 1, FR
Name:
TEPPAZ, GéraldineAddress:
44800 St Herblain, FR
Name:
POIRIER, NicolasAddress:
44119 Treillieres, FR
Name:
VANHOVE, BernardAddress:
44400 Rezé, FR
Name:
GAUTTIER, VanessaAddress:
44400 Rezé, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16306381Date:
21.10.2016Country:
EP
Number:
17305988Date:
24.7.2017Country:
EP
Classification
Categories:
C07K 14/47
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 17.9.2021
Expires: 19.10.2022
Payer: Acumass
Number: 6
Paid: 13.10.2022
Expires: 19.10.2023
Payer: Acumass
Number: 7
Paid: 17.10.2023
Expires: 19.10.2024
Payer: Acumass
Number: 8
Paid: 18.9.2024
Expires: 19.10.2025
Payer: Acumass
Number: 9
Paid: 30.9.2025
Expires: 19.10.2026
Payer: Acumass